Evidence map›Paper›PMID 40022705›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Clinical Investigation of IL-31, TOS and GSH in the Sera of Gastric Cancer Females Patients In Iraq.

Montadher Ali Mahdi, Azal Hmoody Jumaa, Yasser Jassim Dawood

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Montadher Ali MahdiLeading National Cancer Research Centre, University of Baghdad, Baghdad, Iraq.ORCID 0000-0002-6896-9278
Azal Hmoody JumaaLeading National Cancer Research Centre, University of Baghdad, Baghdad, Iraq.ORCID 0000-0001-8497-0001
Yasser Jassim DawoodLeading National Cancer Research Centre, University of Baghdad, Baghdad, Iraq.ORCID 0009-0003-4019-1841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivethe main objective of the study intends to assessing blood levels of interleukin-31 (IL-31), Total Oxidative Stress (TOS), and Glutathione (GSH) and Understanding the relationships between these factors and gastric cancer (GC), additionally studying receiving operation characteristic analysis to understand the effect of this parameters on GC that may reveal new information about the disease's pathogenesis and suggest possible diagnostic and therapeutic strategies.

methodThe study sought to determine the concentrations of anthropometric factors (age and BMI), immunological parameters (IL-31) and parameters related to oxidative stress (TOS and GSH) in the sera of female gastric cancer females patients. The study included 80 people divided into two groups: 40 healthy participants and 40 gastric cancer patients' group, the samples were collected between January to March 2023.

resultsThere is a non-significant (p>0.05) difference in age and BMI between controls and patients. The study found a substantial increase (P<0.001) in IL-31 and TOS levels in GC females matched to controls. However, there was non-significant difference (p>0.05) in GSH levels between healthy controls and GC patients. From ROC analysis it is confirmed that TOS has the highest specificity and sensitivity among the studied parameters.

conclusionThe net result shows that there is an association among the inflammatory immunological parameter IL-31 and GC infection, and that the body's immunity system plays a significant role in fighting this disease, while also demonstrating that oxidative stress plays an important role in the regulation of the disease.

Indexed as

Biomarkers, TumorGlutathioneInterleukinsOxidative StressStomach NeoplasmsAdultBody Mass IndexCase-Control StudiesFemaleFollow-Up StudiesHumansIraqMiddle AgedPrognosisROC CurveBiomarkers, TumorGlutathioneIL31 protein, humanInterleukinsAnti-oxidantGastric cancerGCIL-31TOS

Identifiers

PMID40022705
PMCPMC12118027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.